Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $0.70 in the prior trading day, MEDIROM Healthcare Technologies Inc ADR (NASDAQ: MRM) closed at $0.59, down -15.47%. In other words, the price has decreased by -$15.47 from its previous closing price. On the day, 0.54 million shares were traded. MRM stock price reached its highest trading level at $0.6266 during the session, while it also had its lowest trading level at $0.5715.
Ratios:
Our goal is to gain a better understanding of MRM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.34.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRM now has a Market Capitalization of 4675584 and an Enterprise Value of 3425800960. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.06. Its current Enterprise Value per Revenue stands at 0.479 whereas that against EBITDA is -11.368.
Stock Price History:
The Beta on a monthly basis for MRM is 0.35, which has changed by -0.899661 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, MRM has reached a high of $8.39, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -31.18%, while the 200-Day Moving Average is calculated to be -78.54%.
Shares Statistics:
The stock has traded on average 401.52K shares per day over the past 3-months and 2084140 shares per day over the last 10 days, according to various share statistics. Shares short for MRM as of 1740700800 were 43495 with a Short Ratio of 0.11, compared to 1738281600 on 35183. Therefore, it implies a Short% of Shares Outstanding of 43495 and a Short% of Float of 0.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $8.99B in the next fiscal year. The high estimate is $8.99B and the low estimate is $8.99B.
